VT
The Ventricular arrhythmias page has had a few other minor updates relating to the management of VT.
Dunn RJ
The Ventricular arrhythmias page has had a few other minor updates relating to the management of VT.
The Ventricular arrhythmias page has been updated with a short segment on echocardiographic differentiation of VT from SVT.
The Electrical cardioversion page has been updated with additional information about complications of defibrillation.
The Management of atrial fibrillation page has been updated with additional information about the safety of flecainide for the treatment of AFib.
The Sudden cardiac death page has been updated with additional information about Brugada syndrome epidemiology.
The Syncope page has had a number of updates.
The Difficult intravenous access page has been updated with a number of updates to the Intraosseous access section.
The Difficult intravenous access page has been updated with a short segment on the Contraindications to IO access.
The Pacemakers page has been updated with a revised section on transcutaneous pacing.
The Bradycardias page has been significantly revised and updated. The lack of efficacy of atropine for the treatment of severely symptomatic bradycardia has been highlighted.
The Other arrhythmias page has been updated with some minor updates and wording improvements.
We have just discovered that access to the Electrical cardioversion page through the table of contents has not been working properly and the page heading not displaying as it should. This has now been corrected.
The Electrical cardioversion page has been significantly updated with wording improvements.
An ECG demonstrating tremor artefact has been added to the Introduction to arrhythmias page.
The Introduction to arrhythmias page has had a number of minor updates and wording improvements.
Some minor updates have been made to the Chronic pain page.
The Induction agents page has been updated with some improvements to the segment on ketamine.
A table outlining FFP compatibility according to ABO group has been added to the Clotting factor replacement page.
Some minor additions have been made to the segment on specimen collection for cross matching on the Blood products page.
A short segment on the effects of daratumumab on cross matching and risk of haemolytic reactions has been added to the Blood products page.